AEHR Stock Forecast 2026: Analyst Price Targets

This content is for informational purposes only and does not constitute financial advice. Always consult a licensed financial advisor before making investment decisions.

AEHR 2026 Snapshot

• Analyst consensus: Three active analysts carry an average 12-month price target of $12.33, with all ratings at Buy or equivalent (source: MarketBeat, 2025)
• Base case FY2026 price: $8.00 to $12.00, contingent on moderate SiC demand recovery through fiscal year 2026 (ending May 31, 2026)
• Top bull case catalyst: SiC device manufacturer order recovery accelerating alongside early silicon photonics demand from AI data center customers
• Top risk: Customer concentration: AEHR's revenue depends on a small number of SiC device manufacturers, making any order delay materially damaging to consensus estimates
• Verdict framing: Appropriate for risk-tolerant growth investors if SiC demand recovers; caution warranted for investors with low volatility tolerance

AEHR Stock Forecast 2026: What Investors Need to Know

Aehr Test Systems (NASDAQ: AEHR), a Fremont, California-based semiconductor test equipment company, trades well below its prior peak heading into fiscal year 2026 (ending May 31, 2026). Analyst price targets suggest meaningful upside from current levels, yet the recovery thesis depends entirely on whether Silicon Carbide device manufacturers resume capacity expansion orders after a prolonged inventory correction. For thematic investors evaluating electric vehicle semiconductor infrastructure, AEHR represents an indirect play on the SiC power device supply chain.

AEHR's fiscal year ends May 31, not December 31. Every financial figure labeled "FY2026" in this article refers to the period ending May 31, 2026, not calendar year 2026. This distinction is one the majority of competitor content gets wrong, so it bears stating clearly upfront.

This analysis covers current Wall Street analyst price targets, a scenario-based price model spanning bull, base, and bear cases, AEHR's revenue and earnings per share projections for FY2025 and FY2026, the key growth catalysts, and a scenario-conditioned investment verdict. Investors who track the NASDAQ Composite or the Philadelphia Semiconductor Index (SOX) as benchmarks should note that AEHR typically amplifies broader semiconductor index moves in both directions given its small-cap status and concentrated business model.

For live AEHR stock price data and key statistics, see Aehr Test Systems Stock Price Today: Live AEHRUSDT Data.

What Is Aehr Test Systems? Company Overview

Aehr Test Systems manufactures wafer-level burn-in and test systems for power semiconductor manufacturers worldwide. Wafer-level burn-in testing (a process that stress-tests entire semiconductor wafers before they are cut into individual chips) identifies latent defects at the earliest and least expensive point in the chip manufacturing process.

Data as of 2025. Note: AEHR's fiscal year ends May 31. FY2026 = June 2025 through May 2026.

AEHR's flagship product is the FOX-XP™ Wafer-Level Burn-In and Test System, a multi-wafer simultaneous burn-in platform capable of processing multiple wafers in parallel. Testing at the wafer stage before dicing costs significantly less per chip than testing individual packaged devices. Customers who validate their production processes around the FOX-XP build meaningful switching costs into their supply chains, which supports AEHR's revenue defensibility once a customer relationship is established.

AEHR's revenue model combines FOX-XP hardware sales with recurring wafer board and consumables revenue. System sales are lumpy and tied to customer capital expenditure decisions, while consumables provide a more stable baseline.

Silicon Carbide (SiC), a wide-bandgap semiconductor material that handles higher voltages and temperatures than traditional silicon, is AEHR's primary end market. SiC and Gallium Nitride (GaN) devices both belong to the power semiconductor category, a device class used to control and convert electrical power in applications such as EV inverters and industrial motor drives. AEHR's testing capabilities extend to GaN devices, though SiC dominates its current revenue.

AEHR's customer base consists of SiC device manufacturers. Wolfspeed (NYSE: WOLF), a major SiC wafer and device manufacturer, is among AEHR's significant customers based on widely reported industry coverage. ON Semiconductor (onsemi, NASDAQ: ON), another major SiC device manufacturer, represents the type of customer in AEHR's addressable universe. Investors should verify specific customer relationships through AEHR's most recent 10-K filing with the SEC rather than relying on secondary sources. Unlike Teradyne (NASDAQ: TER), a larger-cap test equipment company with a diversified portfolio spanning logic chips and robotics, AEHR occupies a narrower niche focused exclusively on wafer-level burn-in for power semiconductor devices.

How AEHR Benefits From the Electric Vehicle and SiC Megatrend

AEHR does not sell directly to electric vehicle manufacturers. The company's revenue depends on the SiC device manufacturers who supply EV makers with power chips, making this relationship indirect by one full step in the supply chain.

Electric vehicles require high-density SiC power modules for the main inverter (the component that converts battery DC current to the AC current driving the motor) and for onboard charging systems. As global EV production volumes grew through 2021 and 2022, SiC device manufacturers accelerated capacity expansion, ordering FOX-XP systems to qualify their expanding production lines. When EV demand growth decelerated in 2023 and 2024 and SiC manufacturers accumulated inventory, capacity expansion orders slowed. AEHR's revenue followed.

The long-term secular thesis remains: EV adoption continues to grow globally and SiC remains the dominant power semiconductor for EV drivetrains. Near-term trajectory depends on when SiC manufacturers clear their inventory overhang and resume the capacity expansion orders that drive AEHR's system revenue.

AEHR Stock Analyst Price Targets for 2026

As of 2025, the analyst consensus for Aehr Test Systems reflects a Buy-leaning rating distribution, with price targets carrying meaningful upside from current trading levels contingent on SiC demand recovery through fiscal year 2026. AEHR's active analyst count typically ranges from two to five covering firms, making the consensus more sensitive to a single rating change than would be the case for a large-cap stock.

Last updated: 2025. Verify current targets at MarketBeat or TipRanks.

Source: MarketBeat, TipRanks as of 2025. Price targets are 12-month forward estimates from the date of issue, not specific fiscal year 2026 end-date targets. Verify current coverage at the MarketBeat AEHR page.

All three covering analysts carry Buy or equivalent ratings, with Craig-Hallum's $15.00 target reflecting a more aggressive SiC recovery assumption and potential new customer wins. Northland's $10.00 target applies a more conservative multiple to a moderate recovery scenario.

An analyst price target is a 12-month forward price estimate derived from a valuation model, typically a price-to-sales ratio (P/S ratio, calculated as market capitalization divided by trailing twelve-month revenue) applied to a forward revenue estimate. AEHR has oscillated between profitability and losses across revenue cycles, which makes the P/S multiple a more stable valuation anchor than price-to-earnings. The $5.00 spread between the high and low active targets maps directly to the scenario divergence covered in the next section, reflecting genuine disagreement among analysts about SiC recovery timing.

AEHR Stock Price Forecast 2026: Bull, Base, and Bear Scenarios

AEHR's FY2026 price trajectory depends on a single dominant variable: whether Silicon Carbide device manufacturers resume capacity expansion orders at scale during fiscal year 2026 (ending May 31, 2026). A calendar year 2026 outlook would span both FY2026 (June 2025 through May 2026) and part of FY2027, a distinction that matters when reading analyst estimates, which are published against AEHR's fiscal year calendar rather than the standard December year-end.

The three scenarios below anchor price targets to explicit revenue growth and P/S multiple assumptions. They are illustrative models, not guarantees of future performance.

FY = Aehr Test Systems fiscal year ending May 31, 2026. Scenarios are illustrative models, not analyst forecasts. Baseline assumptions sourced from analyst consensus per MarketBeat and TipRanks, 2025; P/S multiple ranges derived from AEHR's historical valuation band and semiconductor equipment peer comparisons.

Methodology note: Price targets were derived by applying a P/S multiple to the midpoint of the FY2026 revenue estimate range for each scenario. P/S multiples reflect AEHR's historical trading range during prior recovery cycles and demand troughs. These scenarios do not incorporate discounted cash flow inputs and should be read alongside named analyst targets, not as substitutes for them.

Bull case: If SiC device manufacturers accelerate capacity expansion through calendar 2025 and into 2026, driven by improving EV production volumes and clearing inventory overhang, AEHR's system revenue could recover toward prior peak levels. A bull case also requires new customer wins beyond the existing base. Under these conditions, consensus revenue estimates would likely be revised upward materially, and AEHR's P/S multiple could expand toward the 8 to 10x range commanded during peak demand.

A second bull case catalyst operates independently of EV demand: early silicon photonics orders from AI data center customers. If this materializes, revenue estimates and the applied P/S multiple both shift higher, supporting the $14.00 to $18.00 implied price range.

Base case: The consensus scenario assumes a moderate SiC recovery. Existing customers resume incremental system orders as inventory corrects, but no major new capacity expansion wave materializes in FY2026. Revenue grows 20 to 30% over a soft FY2025 base. AEHR approaches or reaches GAAP breakeven, a milestone that could support a valuation re-rating (the market often applies a higher multiple when a company transitions from loss to profitability). The implied base case price of $8.00 to $12.00 aligns with the consensus analyst target range.

Bear case: If EV production growth disappoints through 2025, SiC manufacturers extend their inventory correction, and Wolfspeed's own production ramp delays translate to reduced AEHR system orders, revenue could remain flat or decline from FY2025 levels. GAAP losses deepen, P/S multiples compress toward their historical trough range, and the stock could trade in the $3.00 to $5.50 range. This scenario does not require a structural breakdown in AEHR's competitive position, only a prolonged demand cycle delay.

AEHR Stock Forecast 2025: The Bridge Year

Fiscal year 2025 (ending May 31, 2025) is the base from which the FY2026 recovery thesis is measured. Analyst consensus entering FY2025 projected revenue of approximately $55 to $65 million, representing a significant contraction from the FY2023 peak of roughly $98 million, with GAAP EPS near breakeven (source: MarketBeat, 2025; estimates subject to revision). A weaker-than-expected FY2025 makes the percentage growth targets in the bull and base cases more achievable in absolute dollar terms. A worse-than-expected FY2025 suggests the SiC inventory correction is more prolonged than consensus assumes.

Aehr Test Systems Financials and Growth Drivers

AEHR's revenue peaked in FY2023 at approximately $98 million and contracted sharply in FY2024 as SiC device manufacturers paused capacity expansion. The financial projections table below captures this arc and the consensus recovery path into FY2026.

FY = Aehr Test Systems fiscal year ending May 31. A = actual reported. E = analyst consensus estimate, subject to revision. Source: MarketBeat, TipRanks, and Aehr Test Systems SEC filings via ir.aehr.com, as of 2025.

The earnings per share (EPS, calculated as net income divided by diluted share count) trajectory is where the 2026 story carries the most valuation weight. AEHR has oscillated between modest GAAP profitability and losses across its revenue cycles. A return to GAAP profitability in FY2026 would represent a valuation re-rating catalyst: when a company crosses from loss to profit, the market often applies a higher P/S multiple because the stock shifts from a speculative recovery play to a demonstrably earning business. AEHR currently trades at a P/S ratio well below the elevated multiples it commanded during the FY2023 revenue peak, reflecting the post-boom demand reset. Consensus estimates suggest FY2026 sits at or near the profitability crossover threshold, contingent on revenue recovering to the $65 to $75 million range.

Key Growth Catalysts for AEHR in 2026

Four catalysts could push AEHR's FY2026 revenue above the base case range:

1. SiC demand recovery accelerates. The SiC power semiconductor market is projected to grow from approximately $2 billion in 2023 toward $6 to $8 billion by 2027, according to industry research estimates (figures are directional; sources vary). If EV production volumes recover more strongly than consensus expects, SiC device manufacturers could resume capacity expansion orders at scale. Each FOX-XP system sale represents meaningful hardware revenue and opens a recurring consumables stream.

2. Customer base diversification. If AEHR wins new customers in adjacent SiC markets, such as power modules for industrial applications or renewable energy inverters, that incremental revenue would add directly to the base case without requiring existing customers to accelerate their own capex cycles.

3. Silicon photonics testing orders emerge. AEHR has publicly discussed silicon photonics as a potential addressable market for its reliability testing systems. This catalyst remains early-stage and is not reflected in current analyst consensus estimates, but if it materializes, it represents upside independent of the EV/SiC demand cycle.

4. GaN market expansion. Gallium Nitride (GaN) adoption in fast chargers and consumer power electronics is growing. GaN testing revenue remains secondary to SiC today but could contribute incremental growth as adoption accelerates.

Beyond SiC: AEHR's Silicon Photonics Opportunity

Silicon photonics integrates optical components with silicon chips to enable high-speed, light-based data transmission. According to industry analysts, adoption of silicon photonics devices in AI accelerators and high-bandwidth data center interconnects is growing as hyperscale operators build AI infrastructure.

AEHR has publicly identified this as a potential addressable market for its wafer-level testing methodology. Just as SiC power devices require burn-in testing to eliminate latent defects before deployment, silicon photonics devices require reliability qualification before installation in mission-critical data center hardware.

This opportunity remains an early-stage, unconfirmed revenue stream. AEHR has not announced material silicon photonics customer wins, and analyst consensus models do not incorporate significant silicon photonics revenue for FY2026. If orders materialize into confirmed system purchases, the bull case price scenario becomes more achievable and represents a meaningful diversification of AEHR's revenue base beyond its current SiC dependency.

Key Risks for AEHR Stock in 2026

Key Risks for AEHR Investors in 2026:

• Customer concentration risk: AEHR depends on a small number of SiC device manufacturers for a significant share of revenue
• EV demand deceleration: slower-than-expected EV production growth extends SiC inventory corrections at AEHR's customers
• Small-cap volatility: AEHR's limited float and market cap make price swings more severe than large-cap semiconductor stocks
• Limited analyst coverage: with only two to five active analysts, a single rating change can shift the consensus materially
• Macro headwinds: elevated interest rates and tightening semiconductor manufacturer capex budgets reduce system purchase urgency

The most direct threat to the base case scenario is a prolonged delay in SiC capacity expansion orders from AEHR's significant customers. AEHR experienced revenue declines of approximately 35% in FY2024 when customer order volumes dropped. The stock has also declined significantly from its prior all-time high above $50 per share (reached during the FY2023 SiC boom), with the 52-week range reflecting continued pressure from the inventory correction cycle.

Risk 1: Customer Concentration. Customer concentration risk refers to the danger a company derives a disproportionate share of revenue from a small number of customers, meaning any order reduction from a single customer can have an outsized negative impact on total revenue. AEHR's 10-K filings with the SEC disclose that a small number of customers account for a significant portion of revenue; investors can review exact concentration percentages in the most recent annual report at SEC EDGAR. Wolfspeed (NYSE: WOLF), among AEHR's significant customers, has itself faced financial challenges including debt load pressures and production ramp timeline delays. If Wolfspeed delays FOX-XP system purchases, AEHR's revenue can miss consensus estimates materially. This is the primary reason AEHR stock has been under pressure: EV demand deceleration, SiC inventory corrections, and customer-level delays compressed AEHR's order book below analyst projections.

Risk 2: EV Demand Deceleration and SiC Inventory Correction. AEHR's revenue sits one step removed from EV end demand. When EV growth slowed in 2023 and 2024, SiC manufacturers accumulated inventory and suspended capacity expansion orders. A further EV demand deceleration in 2025 could extend this correction cycle into FY2026, pushing AEHR toward the bear case scenario.

Risk 3: Small-Cap Volatility and Liquidity. AEHR's small market capitalization means institutional selling or a single large block trade can move the price significantly. A 20 to 30% single-day move is not uncommon for AEHR on earnings days or following significant analyst rating changes.

Risk 4: Limited Analyst Coverage. With two to five active covering analysts, a single downgrade or price target reduction can shift the consensus mean by several dollars, creating information asymmetry for retail investors relative to institutional participants.

Risk 5: Macro Headwinds. Elevated interest rates increase the discount rate applied to future earnings, compressing valuation multiples for growth stocks with uncertain near-term profitability. Semiconductor manufacturers managing tight capex budgets may deprioritize system purchases when funding costs are high.

AEHR's short interest has historically been elevated relative to the broader market. Per FINRA short interest data (verify current figures at FINRA.org), short interest as a percentage of float has periodically exceeded 15 to 20% for AEHR. Elevated short interest is a dual signal: bearish conviction from short sellers positioning against the recovery thesis, and potential short squeeze fuel if a major customer order announcement triggers rapid covering.

AEHR Technical Picture: Support Levels and Moving Averages

For active traders: this section covers chart-based price levels for entry and exit timing. Fundamental investors may skip to the verdict section.

Based on AEHR's price history, support has been observed in the $5.00 to $6.00 range, corresponding to multi-year lows established during the deepest phase of the SiC demand correction. Resistance sits in the $10.00 to $12.00 range, aligning with the base case price target band where prior rebound attempts have stalled.

AEHR has spent extended periods trading below its 50-day and 200-day moving averages during the post-peak correction. A sustained reclaim of the 200-day moving average would represent a technical confirmation of the fundamental recovery thesis. Readers should verify current moving average levels at a real-time source, as these figures change daily.

Is AEHR Stock a Buy for 2026? Our Verdict

AEHR stock carries a Buy rating from all three of its active covering analysts, with a consensus 12-month price target of approximately $12.33, implying roughly 50 to 80% upside from recent trading levels contingent on SiC device manufacturer orders recovering through fiscal year 2026 (ending May 31, 2026).

For risk-tolerant growth investors, AEHR warrants consideration under two conditions: first, if SiC demand recovery signs emerge as announced FOX-XP system orders or rising capacity utilization at major SiC manufacturers in the second half of 2025; and second, if AEHR approaches or crosses the GAAP profitability threshold in FY2026, which would likely trigger a valuation re-rating toward the upper end of the analyst target range. Under bull case conditions, the stock could approach the $14.00 to $18.00 range.

Investors should exercise caution if customer concentration risk materializes: specifically, if Wolfspeed or other significant AEHR customers announce further production ramp delays or capex reductions. In that scenario, the bear case price range of $3.00 to $5.50 becomes more probable, and the consensus recovery timeline extends beyond FY2026.

AEHR is not appropriate for capital preservation investors, income-seeking investors, or anyone with a low tolerance for single-stock volatility. Among small-cap semiconductor stocks with 2026 scenario frameworks, investors researching similar analytical structures may find the CRWD stock forecast 2026 scenario analysis and CXMT stock forecast 2026 analyst price targets useful for comparison.

The single catalyst to watch heading into FY2026 is AEHR's quarterly order backlog and system revenue line, reported each quarter (typically in August, November, February, May). A sequential recovery in system orders would signal that the base or bull case is in play. For a deeper scenario-based investment analysis, see AEHRUSDT Stock Prediction 2026: Is Aehr Test Systems a Buy?. For readers interested in how scenario-based price target frameworks apply across cyclical industrial stocks, the CAT stock prediction 2026 price targets provides a comparable methodology in a different sector.

Traders seeking to access AEHR price movements via crypto derivatives can view the AEHRUSDT perpetual contract on Bybit.

This analysis is for informational purposes only. See our full disclaimer below.

Frequently Asked Questions: AEHR Stock Forecast 2026

What is the price target for AEHR stock?

The analyst consensus price target for AEHR stock is approximately $12.33, based on Buy ratings from Craig-Hallum ($15.00), Benchmark ($12.00), and Northland Securities ($10.00) as of 2025 (source: MarketBeat). These are 12-month forward price targets from the date of issue, not specific fiscal year 2026 end-date targets. Verify current targets at MarketBeat or TipRanks, as AEHR reports quarterly and analyst models are updated accordingly.

Is AEHR Test Systems a good stock to buy?

AEHR may suit risk-tolerant growth investors under base case assumptions, where moderate SiC demand recovery supports a consensus price target of approximately $12.33 over the next 12 months. The bull case offers upside toward $14.00 to $18.00 if SiC order recovery accelerates and silicon photonics demand emerges. The bear case carries downside toward $3.00 to $5.50 if customer order delays persist through FY2026 (ending May 31, 2026). AEHR is not appropriate for conservative or capital preservation investors given its small-cap volatility and customer concentration risk.

What does Aehr Test Systems do?

Aehr Test Systems manufactures wafer-level burn-in and test systems, specifically the FOX-XP™ Wafer-Level Burn-In and Test System, which stress-tests entire semiconductor wafers before they are cut into individual chips to eliminate latent defects at the lowest-cost point in the manufacturing process. The company primarily serves Silicon Carbide (SiC) power device manufacturers who supply the electric vehicle and renewable energy industries. AEHR was founded in 1977 and trades on NASDAQ under the ticker AEHR.

Why is AEHR stock down?

AEHR's stock decline reflects three converging pressures: a deceleration in electric vehicle demand growth that reduced orders at SiC chip manufacturers, inventory corrections at those SiC device manufacturers that caused them to pause FOX-XP system purchases, and project-specific delays at key customers including Wolfspeed that pushed expected orders beyond their originally projected timing. These factors are cyclical rather than structural, reflecting where SiC manufacturers sit in their capacity expansion cycle, not a fundamental loss of AEHR's competitive position.

What is AEHR's revenue forecast for 2026?

Analyst consensus estimates AEHR's FY2026 revenue (fiscal year ending May 31, 2026) at approximately $65 to $75 million, representing 10 to 25% growth over FY2025 estimates of $58 to $68 million, contingent on moderate SiC demand recovery (source: MarketBeat, TipRanks, 2025). These estimates are subject to revision following each quarterly earnings release. AEHR's fiscal year ends May 31, so FY2026 covers June 2025 through May 2026.

What are the biggest risks of investing in AEHR?

The five primary risks for AEHR investors heading into 2026 are:

• Customer concentration risk: A small number of SiC device manufacturers account for a significant share of revenue; any customer order delay directly impacts results
• EV demand and SiC inventory cycles: Slower EV production growth or prolonged inventory corrections at SiC manufacturers extend AEHR's revenue recovery timeline
• Small-cap volatility and limited liquidity: The stock can move 20%+ on earnings days; limited market depth amplifies price swings
• Limited analyst coverage: Two to five active analysts means a single rating change can shift consensus materially
• Macro and capex headwinds: Elevated interest rates and tightening semiconductor manufacturer capex budgets can delay system purchase decisions

Is AEHR profitable?

In fiscal year 2024 (ending May 31, 2024), AEHR reported near-breakeven or slightly negative GAAP earnings per share as revenue declined sharply from its FY2023 peak. Analyst consensus for FY2025 projects EPS near breakeven (roughly -$0.15 to +$0.05 GAAP), with FY2026 consensus suggesting a return to modest GAAP profitability in the $0.05 to $0.25 range if revenue recovers as projected (source: MarketBeat, 2025). The FY2026 profitability milestone matters because the market typically assigns a higher P/S multiple to a company that has crossed from loss to profit, a shift known as a valuation re-rating.

How does AEHR benefit from the EV market?

AEHR benefits indirectly from electric vehicle market growth through a specific demand chain: EVs require Silicon Carbide power semiconductors for their main inverters and charging systems, SiC manufacturers must test those chips using wafer-level burn-in systems before shipping, and AEHR's FOX-XP system is the primary tool used for that testing at scale. AEHR does not sell directly to EV manufacturers; its customers are the SiC device manufacturers (such as Wolfspeed and others) who sit one step up the supply chain from EV OEMs. This indirect relationship means AEHR's revenue is affected by both EV end demand and by SiC manufacturer inventory cycles, a compounding dynamic that amplifies upside and downside swings in both directions.

What is AEHRUSDT and can I trade it on Bybit?

AEHRUSDT is a perpetual futures contract on Bybit that tracks the price of Aehr Test Systems stock, quoted and settled in USDT. It allows traders to go long or short on AEHR's price 24/7 without owning actual AEHR shares. For a full explanation of the instrument, see What Is AEHRUSDT? Aehr Test Systems Crypto Trading Pair Explained. For a step-by-step trading guide, see How to Trade AEHRUSDT: The Complete Guide.

Disclaimer

This article is for informational purposes only and does not constitute financial advice, investment advice, trading advice, or a recommendation to buy, sell, or hold any security. All analyst price targets, revenue estimates, and EPS projections referenced herein represent third-party estimates sourced from publicly available financial data platforms including MarketBeat and TipRanks. These estimates are subject to change without notice and may not reflect the most current analyst views. Past performance of AEHR stock is not indicative of future results. Investing in stocks, particularly small-cap equities such as Aehr Test Systems (NASDAQ: AEHR), involves significant risk of loss, including the possible loss of the entire amount invested. The scenarios presented in this article (bull, base, and bear cases) are illustrative models based on stated assumptions and do not constitute guarantees of future performance. Always conduct your own due diligence and consult a licensed financial professional before making any investment decision.